glp-1 heartburn treatment and Treatments What do GLP 1 receptor

Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition

Yes, some lean mass loss can occur during weight loss on GLP-1 medications, but this is usually due to reduced calorie intake, lower protein consumption, and reduced strength training rather than the medication itself

Lastly, when excluding BMI and pre-existing diabetes from the propensity score model, we observed similar findings to completely unadjusted estimates, for both semaglutide and liraglutide

Conclusions/interpretation At current prices, use of SGLT2is, but not GLP-1 RAs, would be cost-effective when considering only their cardiovascular and kidney disease benefits for people with type 2 diabetes